BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27396428)

  • 1. Evaluation of the adjunctive effect of platelet-rich fibrin to enamel matrix derivative in the treatment of intrabony defects. Six-month results of a randomized, split-mouth, controlled clinical study.
    Aydemir Turkal H; Demirer S; Dolgun A; Keceli HG
    J Clin Periodontol; 2016 Nov; 43(11):955-964. PubMed ID: 27396428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of platelet-rich fibrin vs. enamel matrix derivative in the treatment of periodontal intrabony defects: a clinical and cone beam computed tomography study.
    Gupta SJ; Jhingran R; Gupta V; Bains VK; Madan R; Rizvi I
    J Int Acad Periodontol; 2014 Jul; 16(3):86-96. PubMed ID: 25654961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a new-generation platelet-rich fibrin in the treatment of periodontal intrabony defects: a randomized clinical trial.
    Csifó-Nagy BK; Sólyom E; Bognár VL; Nevelits A; Dőri F
    BMC Oral Health; 2021 Nov; 21(1):580. PubMed ID: 34781955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
    Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
    J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periodontal regeneration by leukocyte and platelet-rich fibrin with autogenous bone graft versus enamel matrix derivative with autogenous bone graft in the treatment of periodontal intrabony defects: A randomized non-inferiority trial.
    Paolantonio M; Di Tullio M; Giraudi M; Romano L; Secondi L; Paolantonio G; Graziani F; Pilloni A; De Ninis P; Femminella B
    J Periodontol; 2020 Dec; 91(12):1595-1608. PubMed ID: 32294244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EDTA gel root conditioning: lack of effect on clinical and radiographic outcomes of intrabony defect treatment with enamel matrix derivative.
    Parashis AO; Tsiklakis K; Tatakis DN
    J Periodontol; 2006 Jan; 77(1):103-10. PubMed ID: 16579710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable platelet-rich fibrin with demineralized freeze-dried bone allograft compared to demineralized freeze-dried bone allograft in intrabony defects of patients with stage-III periodontitis: a randomized controlled clinical trial.
    Alshoiby MM; Fawzy El-Sayed KM; Elbattawy W; Hosny MM
    Clin Oral Investig; 2023 Jul; 27(7):3457-3467. PubMed ID: 37002441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins.
    Sculean A; Blaes A; Arweiler N; Reich E; Donos N; Brecx M
    J Periodontol; 2001 Feb; 72(2):190-5. PubMed ID: 11288792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans.
    Gurinsky BS; Mills MP; Mellonig JT
    J Periodontol; 2004 Oct; 75(10):1309-18. PubMed ID: 15562907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
    Velasquez-Plata D; Scheyer ET; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):433-40. PubMed ID: 11990445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enamel matrix derivative versus bioactive ceramic filler in the treatment of intrabony defects: 12-month results.
    Leknes KN; Andersen KM; Bøe OE; Skavland RJ; Albandar JM
    J Periodontol; 2009 Feb; 80(2):219-27. PubMed ID: 19186961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of platelet-rich fibrin in the treatment of decorticated intrabony defects: a randomized clinical trial.
    Ugale GM; Male RB; Bhandari VD; Baghele ON; Metri R; Ugale MS
    Quintessence Int; 2023 Nov; 54(10):808-820. PubMed ID: 37602782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of platelet-rich fibrin for the treatment of periodontal intrabony defects: a systematic review and meta-analysis.
    Miron RJ; Moraschini V; Fujioka-Kobayashi M; Zhang Y; Kawase T; Cosgarea R; Jepsen S; Bishara M; Canullo L; Shirakata Y; Gruber R; Ferenc D; Calasans-Maia MD; Wang HL; Sculean A
    Clin Oral Investig; 2021 May; 25(5):2461-2478. PubMed ID: 33609186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet rich fibrin combined with decalcified freeze-dried bone allograft for the treatment of human intrabony periodontal defects: a randomized split mouth clinical trail.
    Agarwal A; Gupta ND; Jain A
    Acta Odontol Scand; 2016; 74(1):36-43. PubMed ID: 25972081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral.
    Döri F; Arweiler N; Húszár T; Gera I; Miron RJ; Sculean A
    J Periodontol; 2013 Nov; 84(11):1546-55. PubMed ID: 23327604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
    Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
    J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of platelet-rich plasma on the healing of intrabony defects treated with an enamel matrix protein derivative and a natural bone mineral.
    Döri F; Nikolidakis D; Húszár T; Arweiler NB; Gera I; Sculean A
    J Clin Periodontol; 2008 Jan; 35(1):44-50. PubMed ID: 18034853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enamel matrix derivative in the treatment of human intrabony osseous defects.
    Okuda K; Momose M; Miyazaki A; Murata M; Yokoyama S; Yonezawa Y; Wolff LF; Yoshie H
    J Periodontol; 2000 Dec; 71(12):1821-8. PubMed ID: 11156038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes following regenerative therapy of non-contained intrabony defects using a deproteinized bovine bone mineral combined with either enamel matrix derivative or collagen membrane.
    Iorio-Siciliano V; Andreuccetti G; Blasi A; Matarasso M; Sculean A; Salvi GE
    J Periodontol; 2014 Oct; 85(10):1342-50. PubMed ID: 24835417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Radiographic Evaluation of Demineralized Freeze-Dried Bone Allograft Versus Platelet-Rich Fibrin for the Treatment of Periodontal Intrabony Defects in Humans.
    Chadwick JK; Mills MP; Mealey BL
    J Periodontol; 2016 Nov; 87(11):1253-1260. PubMed ID: 27353441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.